Respective roles of human cytochrome P-4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system

Alcoholism: Clinical and Experimental Research

Volumn 22, Issue 9, 1998, Pages 2125-2132

  Salmela, Katja S ^a,b   Kessova, Irina G ^a   Tsyrlov, Ilya B ^a   Lieber, Charles S ^a,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cytochrome P 4501A2; Cytochrome P 4502E1; Cytochrome P 4503A4; Human; Microsomal Ethanol Oxidizing System

Indexed keywords

4 METHYLPYRAZOLE; ACETALDEHYDE; ALCOHOL; ALCOHOL OXIDASE; CYTOCHROME P450 ISOENZYME; DIMETHYLNITROSAMINE DEMETHYLASE; FURAFYLLINE; PHENACETIN O DEETHYLASE; TROLEANDOMYCIN;

ADULT; ALCOHOL METABOLISM; ALCOHOL OXIDATION; ARTICLE; CELL STRAIN HEPG2; CHILD; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER METABOLISM; LIVER MICROSOME; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; CELL LINE; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; ETHANOL; FEMALE; HUMANS; LIVER DISEASES, ALCOHOLIC; MALE; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES;

EID: 0032407278     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000374-199812000-00033     Document Type: Article

References (46)

1. Lieber CS, DeCarli LM: Ethanol oxidation by hepatic microsomes: Adaptive increase after ethanol feeding. Science 162:917-918, 1968
2. Lieber CS, DeCarli LM: Hepatic microsomal ethanol-oxidizing system. In vitro characteristics and adaptive properties in vivo. J Biol Chem 245:2505-2512, 1970
3. Salaspuro MP, Lieber CS: Nonuniformity of blood ethanol elimination: Its exaggeration after chronic consumption. Ann Clin Res 10:294-297, 1978
4. Ohnishi K, Lieber CS: Reconstitution of the microsomal ethanol oxidizing system. Qualitative and quantitative changes of cytochrome P-450 after chronic ethanol consumption. J Biol Chem 252:7124-7131, 1977
5. Koop DR, Morgan ET, Tarr GE, Coon MJ: Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits. J Biol Chem 257:8472-8480, 1982
6. Lasker JM, Raucy J, Kubota S, Bloswick BP, Black M, Lieber CS: Purification and characterization of human liver cytochrome P-450-ALC. Biochem Biophys Res Commun 148:232-238, 1987
7. Wrighton SA, Thomas PE, Ryan DE, Levin W: Purification and characterization of ethanol-inducible human hepatic cytochrome P-450HLj. Arch Biochem Biophys 258:292-297, 1987
8. Nebert DW, Adesnik M, Coon MJ, Estabrook RW, Gonzalez FJ, Guengerich FP, Gunsalus IC, Johnson EF, Kemper B, Levin W, Phillips IR, Sato R, Waterman MR: The P450 gene superfamily: Recommended nomenclature. DNA 6:1-11, 1987
9. Kunitoh S, Tanaka T, Imaoka S, Funae Y, Monna Y: Contribution of cytochrome P450s to MEOS (microsomal ethanol-oxidizing system): A specific and sensitive assay of MEOS activity by HPLC with fluorescence labeling. Alcohol Alcohol 28:63-68, 1993
10. Asai H, Imaoka S, Kuroki T, Monna T, Funae Y: Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s. J Pharmacol Exp Ther 277:1004-1009, 1996
11. Gonzalez FJ, Aoyama T, Gelboin HV: Expression of mammalian cytochrome P-450 using vaccinia virus. Methods Enzymol 206:85-92, 1991
12. Omura T, Sato R: The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J Biol Chem 239:2379-2385, 1964
13. Tsyrlov IB, Goldfarb IS, Gelboin HV: Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expresscd, microsomal, and purified CYP1A1 and CYP1A2. Arch Biochem Biophys 307:259-266, 1993
14. Raucy JL, Lasker JM: Isolation of P450 enzymes from human liver. Methods Enzymol 206:577-587, 1991
15. Newton DJ, Wang RW, Lu AYH: Cytochrome P-450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab Dispos 23:154-158, 1995
16. Tsyrlov IB, Mikhailenko VM, Gelboin HV: Isoenzyme- and species-specific susceptibility of cDNA-expressed CYP1A P450s to different flavonoids. Biochim Biophys Acta 1205:325-335, 1994
17. Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de la Torre R, Davies DS: Furafylline is a potent and selective inhibitor of cytochrome P4501A2 in man. Br J Clin Pharmacol 29:651-663, 1990
18. Kunze KL, Trager WF: Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chem Res Toxicol 6:649-656, 1993
19. NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl Acad Sci USA 86:462-465, 1989
20. Morgan ET, Koop DR, Coon MJ: Catalytic activity of cytochrome P-450 isozyme 3a isolated from liver microsomes of ethanol-treated rabbits. Oxidation of alcohols. J Biol Chem 257:13951-13957, 1982
21. Duescher RJ, Elfarra AA: Determination of p-nitrophenol hydroxylase activity of rat liver microsomes by high-pressure liquid chromatography. Anal Biochem 212:311-314, 1993
22. Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT: Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 48:923-936, 1994
23. Aebi H: Catalase in vitro. Methods Enzymol 105:121-126, 1984
24. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
25. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979
26. 6-testosterone formation. Eur J Biochem 181:331-336, 1989
27. Aoyama T, Yamano S, Waxman DJ, Lapenson DP, Meyer UA, Fischer V, Tyndale R, Inaba T, Kalow W, Gelboin HV, Gonzalez FJ: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. J Biol Chem 264: 10388-10395, 1989
28. Dai Y, Rashba-Step J, Cederbaum AI: Stable expression of human cytochrome P4502E1 in HepG2 cells: Characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry 32: 6928-6937, 1993
29. Jayyosi Z, Knoble D, Mue M, Erick J, Thomas PE, Kelley M: Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. J Pharmacol Exp Ther 273:1156-1161, 1995
30. Teschke R, Gellert J: Hepatic microsomal ethanol-oxidizing system (MEOS): metabolic aspects and clinical implications. Alcohol Clin Exp Res 10:20S-32S, 1986
31. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423, 1994
32. Wrighton SA, Thomas PE, Molowa DT, Haniu M, Shively JE, Maines SL, Watkins PB, Parker G, Mendez-Picon G, Levin W, Guzelian PS: Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase. Biochemistry 25:6731-6735, 1986
33. Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS: The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 10:437-446, 1989
34. Perrot N, Nalpas B, Yang CS, Beaune PH: Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake. Eur J Clin Invest 19:549-555, 1989
35. Sesardic D, Boobis AR, Edwards RJ, Davies DS: A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br J Clin Pharmacol 26:363-372, 1988
36. Watkins PB, Wrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA, Guzelian PS: Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci USA 82:6310-6314, 1985
37. Watkins PB, Murray SA, Winkelman LG, Heuman DM. Wrighton SA, Guzelian PS: Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. J Clin Invest 83:688-697, 1989
38. Forrester LM, Henderson CJ, Glancey MJ, Back DJ, Park BK, Ball SE, Kitteringham NR, McLaren AW, Miles JS, Skett P, Wolf CR: Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J 281:359-368, 1992
39. Lucas D, Berthou F, Dréano Y, Lozac'h P, Volant A, Ménez J-F: Comparison of levels of cytochromes P-450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples. Alcohol Clin Exp Res 17:900-905, 1993
40. Lieber CS: Cytochrome P-4502E1: Its physiological and pathological role. Physiol Rev 77:517-544, 1997
41. Lieber CS: Acetaldehyde and acetate, in Lieber CS (ed): Medical and Nutritional Complications of Alcoholism: Mechanisms and Management. New York, Plenum, 1992. p 37
42. Van Waes L, Lieber CS: Early perivenular sclerosis in alcoholic fatty liver: An index of progressive liver injury. Gastroenterology 73:646-650, 1977
43. Popper H, Lieber CS: Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Pathol 98:695-716, 1980
44. Ratanasavanh D, Beaune P, Morel F, Flinois J-P, Guengerich FP, Guillouzo A: Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology 13:1142-1151, 1991
45. Aoyama T, Gonzalez FJ, Gelboin HV: Human cDNA-expressed cytochrome P-450 1A2: Mutagen activation and substrate specificity. Mol Carcinog 2:192-198;1989
46. Shimada T, Iwasaki M, Martin MV, Guengerich FP: Human liver microsomal cytochrome P-450 enzymes involved in the hioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Cancer Res 49:3218-3228, 1989